Sign in →

Epic Test Code LAB3868 Fat, Feces

Additional Codes

MML Code: FATF

LIS Code: LPTF

NY State Approved

Yes

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Reporting Name

Fat, F

Method Name

Nuclear Magnetic Resonance (NMR) Spectroscopy

Specimen Stability Information

Specimen Type Temperature Time
Fecal Frozen (preferred) 180 days
  Refrigerated  180 days


Necessary Information


Length of collection period is required.



Specimen Required


Patient Preparation:

1. For 3 days prior to and during the collection period:

a. Patient should be on a fat-controlled diet (100-150 g fat per day).

b. No laxatives (particularly mineral oil and castor oil).

c. No synthetic fat substitutes (eg, Olestra) or fat-blocking nutritional supplements.

2. The use of diaper rash ointments will falsely elevate test results. Discontinue use during collection period.

3. Barium interferes with test procedure; a waiting period of 48 hours before stool collection analysis is recommended.

Supplies: Stool Containers - 24, 48, 72 Hours Kit (T291)

Container/Tube: Stool container (T291); complies with shipping requirements, do not use other containers.

Specimen Volume:

Preferred: Entire 48-, or 72-hour collection

Acceptable: Entire 24-hour or random collection

Collection Instructions:

1. All containers must be sent together.

2. The entire collection must contain at least 5 g of feces.

3. For a random collection, a minimum of 5 g (do not send entire collection) is required.

4. The number of containers sent should be indicated on the labels (1 of 4, for example).

Additional Information:

1. Patient can store sample at refrigerate temperature during collection period.

2. A separate order and collection should take place if stool bicarbonate, calcium, chloride, magnesium, osmolality, pH, potassium, sodium, or any microbiology testing is desired.


Specimen Type

Fecal

Specimen Minimum Volume

5 g

Reference Values

TIMED COLLECTION

≥18 years: 2-7 g fat/24 hours

Reference values have not been established for patients who are <18 years of age.

 

RANDOM COLLECTION

All ages: 0-19% fat

Analytic Time

1 day

Day(s) and Time(s) Performed

Monday through Saturday

CPT Code Information

82710

Reject Due To

Hemolysis

NA

Lipemia

NA

Icterus

NA

Other

Preservative, media, or charcoal

 

Cautions

This test is not useful for differentiating among pancreatic diseases.

 

Proper patient preparation is critical (see Specimen Required). Failure to adhere to a fat-controlled diet or to exclude other oils or oil substitutes from the diet may make interpretation difficult.

 

Barium interferes with test procedure; a waiting period of 48 hours before stool collection analysis is recommended.

 

The use of diaper rash ointments will falsely elevate test results. Discontinue use during collection period.

 

The use of charcoal as a marker is not recommended. If charcoal is used, please notify the laboratory.

Specimen Retention Time

7 days

Interpretation

Excretion of more than 7 grams fat/24 hours, when on a diet of 100 to 150 g of fat, is suggestive of a malabsorption defect.

 

Abnormal results from a random specimen should be confirmed by submission of a timed collection.

 

Test values for timed fecal fat collections will be reported in terms of g/24 hours; the duration of the collection may be 24, 48, 72, or 96 hours. Test values for random fecal fat collections will be reported in terms of percent fat.

 

Coefficient of Fat Absorption (CFA) can be calculated as follows:

            (grams fat consumed – grams of fat excreted) x 100

   CFA = --------------------------------------------------------------

                        grams of fat consumed

Clinical Information

Total fecal lipids include glycerides, phospholipids, glycolipids, soaps, sterols, cholesteryl esters, and sphingolipids. Excess fecal fat in stool, (steatorrhea) is indicative of malabsorption disorders, such as pancreatic insufficiency or Whipple disease. Therefore, measurement of the fecal fats can be useful in establishing a diagnosis of such pancreatic diseases as cystic fibrosis, chronic pancreatitis, neoplasia, or stone obstruction, and such intestinal diseases as Whipple disease, regional enteritis, tuberculous enteritis, gluten-induced enteropathy (also called celiac disease or sprue), and the atrophy of malnutrition.

 

Distinguishing free fatty acids from neutral fats, once thought to be helpful in the differential diagnosis of pancreatic disease, has fallen out of favor. Note that the composition of fats in the stool, normally predominately free fatty acids, can change significantly to predominately neutral fatty acids when the patient is on orlistat. This test does not distinguish between free and neutral fatty acids.

Useful For

Diagnosing fat malabsorption due to pancreatic or intestinal disorders

 

Monitoring effectiveness of enzyme supplementation in certain malabsorption disorders

Forms

If not ordering electronically, complete, print, and send a Gastroenterology and Hepatology Client Test Request (T728) with the specimen.